A single-centre study of genetic mutations, audiology, echocardiogram and pulmonary function in Saudi children with osteogenesis imperfecta
-
Noman Ahmad
, Nabil Abdulrahman Aleysae
, MrougeMohamed Sobaihi , NisreenAbdulaziz Naitah , Mohammed Amin Rasol , Amjad Adnan Al-Kouatli , Talal Mohammad Almaghamsi , Emily Lenore Goldman Heaphy , Meshal Hassan Attiyah , MaymoonaAbdelmouz Hrays , Balgees Alghamdi and Ali Saeed Alzahrani
Abstract
Objectives
Osteogenesis imperfecta (OI) is a heterogeneous group of inherited connective tissue disorders, characterised by skeletal fragility. Patients with OI may also exhibit extra-skeletal features like blue or grey scleral colour, fragile skin, easy bruising, joint laxity, short stature, deafness, cardiac valve abnormalities and abnormal pulmonary function. The objective of this study is to describe genetic mutations, prevalence of hearing issues, cardiac complications and impaired pulmonary function in children with OI.
Methods
This is a cross-sectional study of 23 Saudi children aged 6 months to 18 years who were diagnosed with OI. The revised Sillence classification (2,105) was used to classify the OI type. Whole exome sequencing was performed for genetic mutations. The hearing was assessed by either pure-tone audiometry and/or otoacoustic emission testing. Cardiac defects were screened by echocardiograms. Spirometry was performed to assess pulmonary function. Data were analysed with descriptive statistics.
Results
Based on the Sillence classification, 16 patients had OI type III, 6 had type IV and 1 had type I. Of the18 patients who had genetic sequencing, 66.6% had autosomal dominant and 33.3% had autosomal recessive mutations. Among children who had screening, hearing loss was diagnosed in 53% (9/17), congenital cardiac malformations in 26% (5/19) and restrictive lung disease in 70% (7/10).
Conclusions
We found significant extra-skeletal features and a high yield of genetic mutations associated with OI. We suggest further studies to develop a screening protocol for extra-skeletal features in children with OI.
Acknowledgements
We thank Dr. Muhsina Mohammed, Dr. DareenTarim and Dr. Mona Bahasan for data collection.
-
Research funding: This research did not receive funding from public, commercial or not-for-profit sectors.
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: Authors state no conflict of interest.
-
Informed consent: Written informed consent was obtained from the parents.
-
Ethical approval: The study proposal was approved by institutional review board.
References
1. Marini, JC, Forlino, A, Bächinger, HP, Bishop, NJ, Byers, PH, Paepe, AD, et al.. Osteogenesis imperfecta. Nat Rev Dis Primers 2017;3:17052. https://doi.org/10.1038/nrdp.2017.52.Search in Google Scholar PubMed
2. Sillence, D, Senn, A, Danks, DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 1979;16:101–16. https://doi.org/10.1136/jmg.16.2.101.Search in Google Scholar PubMed PubMed Central
3. Cho, TJ, Lee, KE, Lee, SK, Song, SJ, Kim, KJ, Jeon, D, et al.. A single recurrent mutation in the 5′-UTR of IFITM5 causes osteogenesis imperfecta type V. Am J Hum Genet 2012;91:343–8. https://doi.org/10.1016/j.ajhg.2012.06.005.Search in Google Scholar PubMed PubMed Central
4. Trejo, P, Rauch, F. Osteogenesis imperfecta in children and adolescents—new developments in diagnosis and treatment. OsteoporosInt 2016;27:3427–37. https://doi.org/10.1007/s00198-016-3723-3.Search in Google Scholar PubMed
5. El-Hazmi, MA, Al-Swailem, AR, Warsy, AS, Al-Swailem, AM, Sulaimani, R, Al-Meshari, AA. Consanguinity among the Saudi Arabian population. J Med Genet 1995;32:623–6. https://doi.org/10.1136/jmg.32.8.623.Search in Google Scholar PubMed PubMed Central
6. Al‐Owain, M, Al‐Zaidan, H, Al‐Hassnan, Z. Map of autosomal recessive genetic disorders in Saudi Arabia: concepts and future directions. Am J Med Genet 2012;158:2629–40.10.1002/ajmg.a.35551Search in Google Scholar PubMed
7. Alfares, A, Alkuraya, F. An overview of Mendelian disorders in Saudi Arabia, Riyadh, Saudi Arabia. In: Chapter 3 Genetic disorders in the Arab world; 2016:26–37 pp.10.12816/0060137Search in Google Scholar
8. Essawi, O, Symoens, S, Fannana, M, Darwish, M, Farraj, M, Willaert, A, et al.. Genetic analysis of osteogenesis imperfecta in the Palestinian population: molecular screening of 49 affected families. Mol Genet Genomic Med 2018;6:15–26. https://doi.org/10.1002/mgg3.331.Search in Google Scholar PubMed PubMed Central
9. Pillion, JP, Shapiro, J. Audiological findings in osteogenesis imperfecta. J Am AcadAudiol 2008;19:595–601. https://doi.org/10.3766/jaaa.19.8.3.Search in Google Scholar PubMed
10. Rush, ET, Li, L, Goodwin, JL, Kreikemeier, RM, Craft, M, Danford, DA, et al.. Echocardiographic phenotype in osteogenesis imperfecta varies with disease severity. Heart 2017;103:443–8. https://doi.org/10.1136/heartjnl-2016-310099.Search in Google Scholar PubMed
11. Folkestad, L, Hald, JD, Canudas‐Romo, V, Gram, J, Hermann, AP, Langdahl, B, et al.. Mortality and causes of death in patients with osteogenesis imperfecta: a register‐based nationwide cohort study. J Bone Miner Res 2016;31:2159–66. https://doi.org/10.1002/jbmr.2895.Search in Google Scholar PubMed
12. Yimgang, DP, Brizola, E, Shapiro, JR. Health outcomes of neonates with osteogenesis imperfecta: a cross-sectional study. J MaternFetal Neonatal Med 2016;29:3889–93. https://doi.org/10.3109/14767058.2016.1151870.Search in Google Scholar PubMed
13. Liu, Y, Ma, D, Lv, F, Xu, X, Wang, J, Xia, W, et al.. Gene mutation spectrum and genotype-phenotype correlation in a cohort of Chinese osteogenesis imperfecta patients revealed by targeted next generation sequencing. OsteoporosInt 2017;28:2985–95. https://doi.org/10.1007/s00198-017-4143-8.Search in Google Scholar PubMed
14. Zhang, H, Xu, Y, Yue, H, Wang, C, Gu, J, He, J, et al.. Novel mutations of the SERPINF1 and FKBP10 genes in Chinese families with autosomal recessive osteogenesis imperfecta. Int J Mol Med 2018;41:3662–70. https://doi.org/10.3892/ijmm.2018.3542.Search in Google Scholar PubMed
15. Maddirevula, S, Alsahli, S, Alhabeeb, L, Patel, N, Alzahrani, F, Shamseldin, HE, et al.. Expanding the phenome and variome of skeletal dysplasia. Genet Med 2018;20:1609–16. https://doi.org/10.1038/gim.2018.50.Search in Google Scholar PubMed
16. Lv, F, Xu, X, Song, Y, Li, L, Wang, J, Yang, H, et al.. Novel mutations in PLOD2 cause rare bruck syndrome. Calcif Tissue Int 2018;102:296–309. https://doi.org/10.1007/s00223-017-0360-6.Search in Google Scholar PubMed
17. Nawawi, NM, Selveindran, NM, Rasat, R, Chow, YP, Latiff, ZA, Zakaria, SZ, et al.. Genotype-phenotype correlation among Malaysian patients with osteogenesis imperfecta. ClinChimActa 2018;484:141–7. https://doi.org/10.1016/j.cca.2018.05.048.Search in Google Scholar PubMed
18. Bardai, G, Moffatt, P, Glorieux, FH, Rauch, F. DNA sequence analysis in 598 individuals with a clinical diagnosis of osteogenesis imperfecta: diagnostic yield and mutation spectrum. OsteoporosInt 2016;27:3607–13. https://doi.org/10.1007/s00198-016-3709-1.Search in Google Scholar PubMed
19. Willing, MC, Deschenes, SP, Scott, DA,Byers, PH, Slayton, RL, Pitts, SH,et al.. Osteogenesis imperfecta type I: molecular heterogeneity for COL1A1 null alleles of type I collagen. Am J Hum Genet 1994;55:638–47.Search in Google Scholar
20. Tauer, JT, Robinson, ME, Rauch, F. Osteogenesis imperfecta: new perspectives from clinical and translational research. JBMRPlus 2019;3:e10174. https://doi.org/10.1002/jbm4.10174.Search in Google Scholar PubMed PubMed Central
21. BardaiG, Ward, LM, Trejo, P, Moffatt, P, Glorieux, FH, Rauch, F. Molecular diagnosis in children with fractures but no extraskeletal signs of osteogenesis imperfecta. OsteoporosInt 2017;28:2095–101. https://doi.org/10.1007/s00198-017-4031-2.Search in Google Scholar PubMed
22. Cheung, MS, Glorieux, FH, Rauch, F. Natural history of hyperplastic callus formation in osteogenesis imperfecta type V. J Bone Miner Res 2007;22:1181–6. https://doi.org/10.1359/jbmr.070418.Search in Google Scholar PubMed
23. Carré, F, Achard, S, Rouillon, I, Parodi, M, Loundon, N. Hearing impairment and osteogenesis imperfecta: literature review. Eur Ann Otorhinolaryngol Head Neck Dis 2019;136:379–83. https://doi.org/10.1016/j.anorl.2019.05.004.Search in Google Scholar PubMed
24. Garretsen, AJ, Cremers, CW, Huygén, PL. Hearing loss (in non-operated ears) in relation to age in osteogenesis imperfecta type I. Ann OtolRhinolLaryngol 1997;106:575–82. https://doi.org/10.1177/000348949710600709.Search in Google Scholar PubMed
25. Stewart, EJ, O’Reilly, BF. A clinical and audiological investigation of osteogenesis imperfect.ClinOtolaryngol Allied Sci 1989;14:509–14. https://doi.org/10.1111/j.1365-2273.1989.tb00414.x.Search in Google Scholar PubMed
26. Pedersen, U. Hearing loss in patients with osteogenesis imperfecta. A clinical and audiological study of 201 patients.ScandAudiol 1984;13:67–74. https://doi.org/10.3109/14992028409043042.Search in Google Scholar
27. Turkalj, M, Miranović, V, Lulić-Jurjević, R, GjergjaJuraški, R, Primorac, D. Cardiorespiratory complications in patients with osteogenesis imperfecta. Paediatr Croat 2017;61:106–12.Search in Google Scholar
28. Vetter, U, Maierhofer, B, Müller, M, Lang, D, Teller, WM, Brenner, R,et al.. Osteogenesis imperfecta in childhood: cardiac and renal manifestations. Eur J Pediatr 1989;149:184–7. https://doi.org/10.1007/bf01958277.Search in Google Scholar
29. Hortop, J, Tsipouras, P, Hanley, J, Maron, BJ, Shapiro, JR. Cardiovascular involvement in osteogenesis imperfecta. Circ J 1986;73:54–61. https://doi.org/10.1161/01.cir.73.1.54.Search in Google Scholar PubMed
30. Alaei, MR, Mosallanejad, A, Fallah, S, Shakiba, M, Saneifard, H, Alaei, F, et al.. Echocardiographic findings in children with osteogenesis imperfecta. Casp J Pediatr March 2019;5:329–33.Search in Google Scholar
© 2021 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Review Article
- Congenital hyperinsulinism: recent updates on molecular mechanisms, diagnosis and management
- Original Articles
- Weight changes of children in 1 year during COVID-19 pandemic
- Three novel mutations of the BCKDHA, BCKDHB and DBT genes in Chinese children with maple syrup urine disease
- Rates of adrenal insufficiency using a monoclonal vs. polyclonal cortisol assay
- Hyperinsulinemic hypoglycemia in growth restricted convalescent preterm neonates: clinical characteristics and impediments to early diagnosis
- Identification of three novel pathogenic mutations in cystathionine beta-synthase gene of Pakistani intellectually disabled patients
- The prevalence of incidental finding of gynecomastia on thoracic computed tomography in the pediatric age group
- The prevalence of hypertension and elevated blood pressure and its correlation with overweight/obesity among students aged 6–17 years in Suzhou
- Investigation of androgen receptor gene CAG repeat length polymorphism in pubertal gynecomastia
- A single-centre study of genetic mutations, audiology, echocardiogram and pulmonary function in Saudi children with osteogenesis imperfecta
- A 10-year retrospective single-center study of alpha-fetoprotein and beta-human chorionic gonadotropin in Romanian children with (para)gonadal tumors and cysts
- Clinical, pathological and molecular spectrum of patients with glycogen storage diseases in Pakistan
- Allelic dropout in PAH affecting the results of genetic diagnosis in phenylketonuria
- Short Communication
- Role of the SARS-CoV-2 virus in the appearance of new onset type 1 diabetes mellitus in children in Gran Canaria, Spain
- Case Reports
- 3-M syndrome – a primordial short stature disorder with novel CUL7 mutation in two Indian patients
- The coincidence of two rare diseases with opposite metabolic phenotype: a child with congenital hyperinsulinism and Bloom syndrome
- Growth hormone deficiency in a child with benign hereditary chorea caused by a de novo mutation of the TITF1/NKX2-1 gene
- Identification of a novel mutation in the PHKA2 gene in a child with liver cirrhosis
Articles in the same Issue
- Frontmatter
- Review Article
- Congenital hyperinsulinism: recent updates on molecular mechanisms, diagnosis and management
- Original Articles
- Weight changes of children in 1 year during COVID-19 pandemic
- Three novel mutations of the BCKDHA, BCKDHB and DBT genes in Chinese children with maple syrup urine disease
- Rates of adrenal insufficiency using a monoclonal vs. polyclonal cortisol assay
- Hyperinsulinemic hypoglycemia in growth restricted convalescent preterm neonates: clinical characteristics and impediments to early diagnosis
- Identification of three novel pathogenic mutations in cystathionine beta-synthase gene of Pakistani intellectually disabled patients
- The prevalence of incidental finding of gynecomastia on thoracic computed tomography in the pediatric age group
- The prevalence of hypertension and elevated blood pressure and its correlation with overweight/obesity among students aged 6–17 years in Suzhou
- Investigation of androgen receptor gene CAG repeat length polymorphism in pubertal gynecomastia
- A single-centre study of genetic mutations, audiology, echocardiogram and pulmonary function in Saudi children with osteogenesis imperfecta
- A 10-year retrospective single-center study of alpha-fetoprotein and beta-human chorionic gonadotropin in Romanian children with (para)gonadal tumors and cysts
- Clinical, pathological and molecular spectrum of patients with glycogen storage diseases in Pakistan
- Allelic dropout in PAH affecting the results of genetic diagnosis in phenylketonuria
- Short Communication
- Role of the SARS-CoV-2 virus in the appearance of new onset type 1 diabetes mellitus in children in Gran Canaria, Spain
- Case Reports
- 3-M syndrome – a primordial short stature disorder with novel CUL7 mutation in two Indian patients
- The coincidence of two rare diseases with opposite metabolic phenotype: a child with congenital hyperinsulinism and Bloom syndrome
- Growth hormone deficiency in a child with benign hereditary chorea caused by a de novo mutation of the TITF1/NKX2-1 gene
- Identification of a novel mutation in the PHKA2 gene in a child with liver cirrhosis